Responses
Regular and Young Investigator Award Abstracts
Education and Treatment Management
904 A case report of metastatic castration resistant prostate cancer patient with AR F877L mutation treated with KPG-121 in combination with enzalutamide
Compose a Response to This Article
Other responses
No responses have been published for this article.
